| # | Drug | Count |
|---|---|---|
| 0 | RITUXIMAB | 11 |
| 1 | PREDNISONE | 8 |
| 2 | DALFAMPRIDINE | 7 |
| 3 | ERGOCALCIFEROL | 6 |
| 4 | BACLOFEN | 4 |
| 5 | CYCLOPHOSPHAMIDE | 4 |
| 6 | CYCLOPHOSPHAMIDE FOR INJECTION | 4 |
| 7 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 4 |
| 8 | CYCLOSPORINE | 4 |
| 9 | DICLOFENAC SODIUM | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SULFACETAMIDE SODIUM | 1 | 0.0020 |
| 1 | EQUINE THYMOCYTE IMMUNE GLOBULIN | 2 | 0.0019 |
| 2 | RALTEGRAVIR | 4 | 0.0008 |
| 3 | MOGAMULIZUMAB-KPKC | 1 | 0.0007 |
| 4 | GINKGO BILOBA | 1 | 0.0007 |
| 5 | ATROPINE SULFATE INJECTION | 1 | 0.0004 |
| 6 | ATROPINE SULFATE MONOHYDRATE | 1 | 0.0004 |
| 7 | AMPICILLIN SODIUM AND SULBACTAM SODIUM | 1 | 0.0004 |
| 8 | PENICILLIN V POTASSIUM | 1 | 0.0004 |
| 9 | PRASTERONE | 1 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Chemokine Receptor Type 4 Interaction [EPC] | 1 | 0.0007 |
| 1 | Carnitine Analog [EPC] | 1 | 0.0003 |
| 2 | Provitamin D2 Compound [EPC] | 6 | 0.0002 |
| 3 | Bismuth [EPC] | 1 | 0.0002 |
| 4 | CD38-directed Cytolytic Antibody [EPC] | 1 | 0.0002 |
| 5 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 6 | 0.0001 |
| 6 | Chloride Channel Activator [EPC] | 1 | 0.0001 |
| 7 | Potassium Channel Blocker [EPC] | 7 | 0.0001 |
| 8 | Human Immunoglobulin G [EPC] | 2 | 0.0001 |
| 9 | Sympathomimetic-like Agent [EPC] | 3 | 0.0001 |